Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tolazoline hydrochloride (NSC35110 (hydrochloride)) is a non-selective competitive α-adrenergic receptor antagonist used in treatment of persistent pulmonary hypertension of the newborn.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
500 mg | 在庫あり | ¥ 9,000 | |||
1 g | 在庫あり | ¥ 13,000 | |||
5 g | 在庫あり | ¥ 27,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,000 |
説明 | Tolazoline hydrochloride (NSC35110 (hydrochloride)) is a non-selective competitive α-adrenergic receptor antagonist used in treatment of persistent pulmonary hypertension of the newborn. |
In vivo | In cases of persistent pulmonary hypertension of the newborn (PPHN), Tolazoline acts as a pulmonary vasodilator, effectively reducing pulmonary vascular resistance (PVR) and pulmonary arterial pressure. Additionally, within the human radial artery, Tolazoline blocks α-adrenergic activity, significantly counteracting vascular spasms. |
別名 | Imidaline hydrochloride, Imidaline (hydrochloride), Benzidazol hydrochloride, Tolazoline HCl, NSC35110 (hydrochloride) |
分子量 | 196.68 |
分子式 | C10H13ClN2 |
CAS No. | 59-97-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 36 mg/mL (183 mM)
DMSO: 55 mg/mL (279.64 mM)
Ethanol: 37 mg/mL (188.1 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tolazoline hydrochloride 59-97-2 GPCR/G Protein Neuroscience Adrenergic Receptor Tolazoline Hydrochloride Imidaline hydrochloride inhibit Imidaline Hydrochloride NSC35110 Imidaline Beta Receptor Benzidazol Hydrochloride Inhibitor Imidaline (hydrochloride) Benzidazol hydrochloride Tolazoline HCl NSC35110 (hydrochloride) NSC-35110 Tolazoline NSC 35110 inhibitor